. . .

Stock News in Focus: DelMar Pharmaceuticals (NASDAQ:DMPI)

DelMar Pharmaceuticals (NASDAQ:DMPI) stock identified change of 33.06% away from 52-week low price and recently located move of -92.36% off 52-week high price. It has market worth of $6.49M . DMPI stock has been recorded -14.00% away from 50 day moving average and -77.38% away from 200 day moving average. Moving closer, we can see that shares have been trading 9.87% off 20-day moving average.

DelMar Pharmaceuticals (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, announced that Mr. Saiid Zarrabian, president and chief executive officer of DelMar, will be a featured presenter at the 5th Annual Dawson James Small Cap Growth Conference on October 29, 2019 at 4:05 PM Eastern Time. The conference is being held at the Wyndham Grand Hotel in Jupiter, Florida.

Mr. Zarrabian will provide an overview of the Company’s business model and growth strategy and will be available for one-on-one meetings.

 The Healthcare sector company, DelMar Pharmaceuticals noticed change of 8.90% to $0.53 along volume of 218905 shares in recent session compared to an average volume of 819.42K. The stock observed return of 20.26% in 5 days trading activity. The stock was at -9.37% over one month performance. DMPI’s shares are at -66.36% for the quarter and driving a -92.13% return over the course of the past year and is now at -84.36% since this point in 2018. 

 The average volatility for the week at 15.32% and for month was at 11.48%. There are 12.14M shares outstanding and 10.66M shares are floated in market. Right now the stock beta is 1.26. 

Leave a Reply

Your email address will not be published. Required fields are marked *